Gilead Sciences Inc (GILD)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$167.45
Buy
$167.59
$-0.56 (-0.33%)
Prices updated at 16 Nov 2026, 20:20 EST
| Prices minimum 15 mins delay
Prices in USD
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovald ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $171.80 - $166.92 | |
| $176.58 - $116.88 | |
| 1.90 | |
| 208,476.11m | |
| - | |
| - | |
| 2,365,440 | |
| 15.99 | |
| 6,845,457.94 | |
| -0.05 | |
| 1,240.68m | |
| US3755581036 | |
| 6.78 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.